基因测序在塑造胎儿治疗中日益扩大的作用:临床与伦理考量
本文综述了下一代测序在产前决策中的作用,指出早期基因检测可支持风险分层、精准及时诊断,从而直接指导胎儿手术与分子治疗的 eligibility,并影响产前干预、产后准备、咨询及生殖规划;人工智能的整合有望简化诊断、咨询与治疗可及性,但公平可及、偶然发现、意义不明变异、不完全外显及罕见变异表型预测不确定等伦理与社会挑战仍然存在。
要点
- 早期基因检测可支持风险分层与精准诊断,直接指导胎儿手术和分子治疗的准入。
- 早期诊断可指导产前干预、筛选需产后准备的病例,并影响咨询与生殖规划。
- 公平可及、偶然发现、意义不明变异、不完全外显及表型预测不确定是主要伦理挑战。
核心结论
- 本综述强调早期基因检测与宫内干预之间的密切相互作用,并强调产前基因组研究与照护中需要公平、精准且基于社区信息的实践。
研究设计与样本
- 综述,检索范围未报告。
主要发现
- 下一代测序使早期基因检测成为可能,通过支持风险分层、精准及时诊断,在产前决策中发挥关键作用,并直接指导胎儿手术与分子治疗的准入。
- 早期诊断通过指导产前干预、筛选可能从产后准备中获益的病例(当早期产后治疗改变结局时),以及在显著影响妊娠决策时指导咨询和生殖规划,使产前与产后照护均获益。
- 将人工智能整合到产前照护中,有望提供端到端解决方案,简化诊断、咨询以及标准与实验性宫内干预的可及性。
- 显著的伦理与社会挑战仍然存在,包括检测与照护可及性的公平性、偶然发现、意义不明变异、不完全外显以及罕见变异与疾病表型预测的不确定性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In utero interventions are transformative in addressing genetic and anatomic conditions during fetal development. Next generation sequencing enables early genetic testing, playing a pivotal role in prenatal decision-making by supporting risk stratification, precise and timely diagnosis, which directly informs eligibility for fetal surgical and molecular therapies. Early diagnosis benefits both prenatal and postnatal care by guiding prenatal interventions, or selecting cases that might benefit from postnatal preparedness (when early postnatal treatment alters outcomes), and informing counseling (when it significantly influences pregnancy decision-making) and reproductive planning. The integration of artificial intelligence into prenatal care holds the promise of end-to-end solutions that streamline diagnosis, counseling, and access to both standard and experimental in utero interventions. However, significant ethical and social challenges remain, including equity in access to testing and care, incidental findings, variants of uncertain significance, incomplete penetrance and uncertain phenotype prediction of rare variants and disorders. These complexities raise important questions about reproductive autonomy and justice and responsible use of emerging technologies. This review emphasizes the intimate interplay between early genetic testing and in utero interventions, while highlighting the need for equitable, precise, and community-informed practices in prenatal genomic research and care.
引用
- Shear MA, Borges B, Lianoglou BR, et al. The Expanding Role of Gene Sequencing in Shaping Fetal Therapies: Clinical and Ethical Considerations. Prenat Diagn. 2025. PMID: 40973987. doi:10.1002/pd.6890
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。